Heat Shock Proteins and PD-1/PD-L1 as Potential Therapeutic Targets in Myeloproliferative Neoplasms

SIMPLE SUMMARY: Myeloproliferative neoplasms (MPN), which are a heterogeneous group of rare disorders that affect blood cell production in bone marrow, present many significant challenges for clinicians. Though considerable progress has been made, in particular with the JAK1/2 inhibitor ruxolitinib,...

Descripción completa

Detalles Bibliográficos
Autores principales: De Almeida, Steven, Regimbeau, Mathilde, Jego, Gaëtan, Garrido, Carmen, Girodon, François, Hermetet, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563255/
https://www.ncbi.nlm.nih.gov/pubmed/32932806
http://dx.doi.org/10.3390/cancers12092592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563255/
https://www.ncbi.nlm.nih.gov/pubmed/32932806
http://dx.doi.org/10.3390/cancers12092592

Ejemplares similares